MedTrace Logo

Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

NCT02905851 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2018-07-02

No results posted yet for this study

Summary

To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris

Conditions

  • Acne Vulgaris

Interventions

OTHER

Feedback group

Monitoring ability to use teledermatology to modify antibiotic burden

OTHER

Non Feedback group

To use as control to see if antibiotic burden has been reduced in the active feedback group

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Raja Sivamani, MD · UC Davis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02905851 on ClinicalTrials.gov